Elevated levels of serum advanced glycation end products in patients with non‐alcoholic steatohepatitis

Abstract

The present data suggest that the sustained increase of glyceraldehyde-derived AGE could at least in part contribute to the pathogenesis of NASH. The serum glyceraldehyde-derived AGE level may be a useful biomarker for discriminating NASH from simple steatosis.